Business

EBay's Donahoe buys GSIC

eBAY acquires GSIC

EBAY CEO, John Donahoe, has become the owner of the biggest e-commerce marketplace with his acquisition of GCIS.

FTC tightens debt collections post-mortem

Washington -- Consumer advocates say the U.S. Federal Trade Commission has asked for trouble by revising rules for collectors chasing debt from people who have died.

The new rules allow for a wider circle of people to be contacted, beyond family members and the legal executor of the estate. There is also the term "spouse" that some advocates say is inaccurate as a marriage ends when one of the partners dies. The Washington Post reported Monday.

Some advocates warn that some debt collectors will press even friends to pay the debts of someone who has died, using a "moral obligation" argument, the Post said.

Is Dow the Perfect Stock?

 Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everythingyou could possibly want? One thing's for sure: If you don't look, you'll never find truly great investments. So let's first take a look at what you'd want to see from a perfect stock, and then decide if Dow Chemical (NYSE: DOW) fits the bill.

 

Guess What? Harvard Says You're Dumb

"As stock markets slid in March, Judy Brady lay awake at night thinking about her portfolio. 'My retired friends who had all CDs and gold, and they were still making money, and my investments just kept going and going,' she said. 'I thought: I can't afford to lose all this.' So the 70-year-old retiree in Schaumburg, Ill., sold most of her stocks."
 -- The Wall Street Journal, May 18, 2009

 

Does EMC Pass Buffett's Test?

We'd all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital (ROIC) to help determine whether a company has an economic moat -- the ability to earn returns on its money beyond that money's cost.

Great Call on Dendreon! What's Next?

Investors in our Motley Fool CAPS community have given Dendreon's(Nasdaq: DNDN) stock two stars out of a possible five. The high-flying biotech behind the recently approved cancer vaccine Provenge has collected 293 underperform ratings to go along with its 1,222 outperforms on CAPS.

Make Money From This Megatrend

Economists and investors alike have worried about the possibility of deflation. There's absolutely no sign of deflationary pressure in the price of food commodities, however, and smart investors can take advantage of the opportunity to invest in companies that will benefit and get rid of stocks that could suffer.

Meet the Cash Kings of Gold

As an investor, it pays to follow the cash. If you figure out how a company moves its money, you might eventually find some of that cash flowing into your pockets.

This Just In: Upgrades and Downgrades

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." So you might think we'd be the last people to give virtual ink to such "news." And we would be -- if that were all we were doing.

Apple Takes One More Step Into Your Living Room

In a move that's long overdue, Bloomberg reports that Apple (Nasdaq: AAPL) is getting into digital rentals of television show episodes.

Why Apple and Facebook May Be BFFs

On Wednesday, Facebook introduced a new location-based service that allows users to share their location with friends. With more than 500 million members, Facebook is now the third-most-popular video site on the Web according to comScore, trailing only Google (Nasdaq: GOOG) and Yahoo!.

These 7 Stocks Are Making the Right Move

People have argued for years about whether the bond market is a bubble waiting to burst or will continue to push rates down to historic lows. Regardless of prevailing opinion, though, many companies definitely believe that now's the time to sell bonds, as they rush to issue debt at amazingly low rates before they start to rise again.